Breaking News

Cambodia Urges Stronger ASEAN-Australia Cooperation in Skills and Education

Samdech Khuon Sudary Meets Hungarian Deputy Speaker M¡rta M¡trai to Strengthen Friendship and Parliamentary Cooperation

Cambodia Committed to Working Closely with New Zealand and ASEAN to Maximise Benefits of ANNZFTA and RCEP

Cambodian Prime Minister Highlights China’s Role in ASEAN Energy Transition

Outcomes of 28th ASEAN-China Summit, ASEAN-New Zealand Commemorative Summit, and ASEAN-Australia Summit

Cambodia and Russia to Strengthen Bilateral Ties Across Multiple Sectors

Mekong-Lancang Nations Strengthen Cooperation for a Mine-Free Region

Cambodian Dignitary Highlights Buddhism’s Role in Peace and Sustainable Development

  • June 13, 2026
Search
Close this search box.

Category: Asean

Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease

May 19, 2026

SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) — Risen Pharma, a clinical-stage biotech company focusing on the development and commercialization of high-need, patient-accessible therapeutics, today announced the initiation of a Phase 2 clinical study in China of RP902, an oral small-molecule drug developed to address significant unmet medical needs in patients

Read more

Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease

May 19, 2026

SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) — Risen Pharma, a clinical-stage biotech company focusing on the development and commercialization of high-need, patient-accessible therapeutics, today announced the initiation of a Phase 2 clinical study in China of RP902, an oral small-molecule drug developed to address significant unmet medical needs in patients

Read more

Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease

May 19, 2026

SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) — Risen Pharma, a clinical-stage biotech company focusing on the development and commercialization of high-need, patient-accessible therapeutics, today announced the initiation of a Phase 2 clinical study in China of RP902, an oral small-molecule drug developed to address significant unmet medical needs in patients

Read more

Jenfi Surpasses US$100 Million in SME Financing Across Southeast Asia

May 19, 2026

SINGAPORE, May 19, 2026 (GLOBE NEWSWIRE) — Jenfi, a Southeast Asia-focused SME credit platform, today announced that it has surpassed US$100 million in cumulative financing originations across the region, marking a significant milestone in the company’s continued expansion across Singapore and Vietnam. Operating across two of Southeast Asia’s largest SME

Read more

Jenfi Surpasses US$100 Million in SME Financing Across Southeast Asia

May 19, 2026

SINGAPORE, May 19, 2026 (GLOBE NEWSWIRE) — Jenfi, a Southeast Asia-focused SME credit platform, today announced that it has surpassed US$100 million in cumulative financing originations across the region, marking a significant milestone in the company’s continued expansion across Singapore and Vietnam. Operating across two of Southeast Asia’s largest SME

Read more

Jenfi Surpasses US$100 Million in SME Financing Across Southeast Asia

May 19, 2026

SINGAPORE, May 19, 2026 (GLOBE NEWSWIRE) — Jenfi, a Southeast Asia-focused SME credit platform, today announced that it has surpassed US$100 million in cumulative financing originations across the region, marking a significant milestone in the company’s continued expansion across Singapore and Vietnam. Operating across two of Southeast Asia’s largest SME

Read more

Recent News

Copyright © 2026 Myanmar Inquirer All Rights Reserved.